Literature DB >> 18751965

[Atypical Parkinson syndromes].

A Strzelczyk1, J C Möller, M Stamelou, A Matusch, W H Oertel.   

Abstract

At the moment atypical Parkinson syndromes have unfavorable prognoses and show little response to dopaminergic medication. Early differential diagnosis of these disorders from idiopathic Parkinson syndrome is of pivotal clinical relevance. In case of future causal, neuroprotective therapeutic strategies, early diagnosis will allow a timely start of therapy. In the early stage of disease, it might be difficult clinically to distinguish multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration from idiopathic Parkinson syndrome. Additional electrophysiological, imaging, and nuclear medical investigations may support the clinical diagnosis. During disease progression clinical signs indicative of an atypical Parkinson syndrome should always warrant reevaluation of the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751965     DOI: 10.1007/s00115-008-2559-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  84 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

Review 2.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

3.  Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type.

Authors:  Wolfgang H Oertel; Tobias Wächter; Niall P Quinn; Gudrun Ulm; Dirk Brandstädter
Journal:  Mov Disord       Date:  2003-04       Impact factor: 10.338

4.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

Authors:  G K Wenning; Y Ben Shlomo; M Magalhães; S E Daniel; N P Quinn
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

Review 5.  The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

Authors:  S Braune
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

Review 6.  Progressive supranuclear palsy: a systematic review.

Authors:  L Rampello; V Buttà; R Raffaele; I Vecchio; G Battaglia; G Cormaci; A Alvano
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Not paralysis, but dystonia causes stridor in multiple system atrophy.

Authors:  Ilaria Maria Merlo; Antonio Occhini; Claudio Pacchetti; Enrico Alfonsi
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

9.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

10.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.